
Sign up to save your podcasts
Or
AMCP Unscripted discusses upcoming Cabinet confirmations, drug policy, biosimilars, 340B, and more with Andrew McKechnie from the Tiber Creek Group, Adam Colborn from AMCP, and Geni Tunstall from AMCP.
AMCP Unscripted discusses upcoming Cabinet confirmations, drug policy, biosimilars, 340B, and more with Andrew McKechnie from the Tiber Creek Group, Adam Colborn from AMCP, and Geni Tunstall from AMCP.